Heart pump device market accounted for approximately US$ 2.1 Billion in 2019. It is anticipated to grow at a CAGR of ~ 17% from 2020 to 2030.
The continual growth of the heart pump device market can be attributed to several factors, which have led to the wide-scale adoption of these products for the treatment of cardiovascular disorders. Moreover increasing medical tourism, safe procedures, and long-term survival are contributing to the substantial growth of the global heart pump device market between 2020 and 2030. To gain better insights, prominent players in the market are focusing on new product launches along with technological advancements. For Instance, in February 2020, Abbott received U.S. FDA’s breakthrough device designation for the development of a Fully Implantable Left Ventricular Assist System (FILVAS).
Major Key Players of the Heart Pump Device Market are:
Abbott Laboratories, Abiomed, Terumo Europe NV, Medtronic PLC, SynCardia Systems LLC. Teleflex Incorporated, Berlin Heart Gmbh, Jervik Heart Inc., Reliant Heart Inc., and Cardiac Assist Inc., among others.
No comments:
Post a Comment